Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Certain genes are linked to the risk of developing Alopecia Areata.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Alopecia areata involves immune response and gene changes affecting hair loss.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Leontopodium alpinum extract may help reduce hair shedding by keeping hair in the growth phase longer.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

New therapies like JAK inhibitors, PRP, and stem cell treatments show promise for better alopecia management.

Different substances affect hair and skin cell growth in various ways.

Active oxygen scavengers can reverse the suppression of hair cell growth caused by androgens.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Nerves and chemicals in the body can affect hair growth and loss.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.